CANCER drug treatments are under scrutiny as a cause of soaring healthcare and claims costs. Current cancer patients will have to brace for changes.
Home Investments Fine-tuning MediShield Life: From 2022, cancer drug treatments must be in “positive...
- Advertisement -
Most Popular
Helen Wong to retire as OCBC CEO; Tan Teck Long named successor
Wong had informed the board last year of her intention to retire for family reasons; she will remain as chairman of OCBC...
China’s GDP growth set to slow, raising pressure on policymakers
Analysts expect the country’s central bank to cut the key policy rate by 10 bps in Q4
Citigroup sets mid-2026 target of 1,150 for MSCI’s global equity index
The brokerage’s expected year-end EPS growth of above 11% for the ACWI falls below consensus estimates
